Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2JEY

Mus musculus acetylcholinesterase in complex with HLo-7

Summary for 2JEY
Entry DOI10.2210/pdb2jey/pdb
Related1C2B 1C2O 1J06 1J07 1KU6 1MAA 1MAH 1N5M 1N5R 1Q83 1Q84 2C0P 2C0Q 2H9Y 2HA0 2HA2 2HA3 2HA4 2HA5 2HA6 2HA7 2JEZ 2JF0
DescriptorACETYLCHOLINESTERASE, 1-[({2,4-BIS[(E)-(HYDROXYIMINO)METHYL]PYRIDINIUM-1-YL}METHOXY)METHYL]-4-CARBAMOYLPYRIDINIUM, HEXAETHYLENE GLYCOL, ... (4 entities in total)
Functional Keywordsacetylcholinesterase, alternative splicing, oxime, mouse, hlo-7, synapse, membrane, hydrolase, neurotransmitter degradation, mus musculus, glycoprotein, serine esterase
Biological sourceMUS MUSCULUS (MOUSE)
Total number of polymer chains2
Total formula weight121412.95
Authors
Ekstrom, F.,Astot, C.,Pang, Y.P. (deposition date: 2007-01-25, release date: 2007-07-03, Last modification date: 2024-10-23)
Primary citationEkstrom, F.J.,Astot, C.,Pang, Y.
Novel Nerve-Agent Antidote Design Based on Crystallographic and Mass Spectrometric Analyses of Tabun-Conjugated Acetylcholinesterase in Complex with Antidotes.
Clin.Pharmacol.Ther., 82:282-, 2007
Cited by
PubMed Abstract: Organophosphorus compound-based nerve agents inhibit the essential enzyme acetylcholinesterase (AChE) causing acute toxicity and death. Clinical treatment of nerve-agent poisoning is to use oxime-based antidotes to reactivate the inhibited AChE. However, the nerve agent tabun is resistant to oximes. To design improved oximes, crystal structures of a tabun-conjugated AChE in complex with different oximes are needed to guide the structural modifications of known antidotes. However, this type of structure is extremely challenging to obtain because both deamidation of the tabun conjugate and reactivation of AChE occur during crystallographic experiments. Here we report, for the first time, the crystal structures of Ortho-7 and HLö-7 in complex with AChE that is conjugated to an intact tabun. These structures were determined by our new strategy of combining crystallographic and mass spectrometric analyses of AChE crystals. The results explain the relative reactivation potencies of the two oximes and offer insights into improving known medical antidotes.
PubMed: 17443135
DOI: 10.1038/SJ.CLPT.6100151
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon